SNDX-6532

· Syndax Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNDX-6532, covering 2023-03-31 to 2023-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma [Phase 2]

See pricing